Eva Prieschl-Grassauer
Founder bei MARINOMED BIOTECH AG
Profil
Eva Prieschl-Grassauer is the founder and Chief Scientific Officer at Marinomed Biotech AG, which is founded in 2006.
She previously worked as Head-Laboratory at AUSTRIANOVA Biomanufacturing AG from 2002 to 2006, and as Head-Allergy Program at Novartis Austria GmbH.
She also worked as a Product Manager at Wyeth Pharmaceuticals BV in 2002 and as a Project Manager at Onepharma in 2006.
Dr. Prieschl-Grassauer holds a doctorate degree from the University of Vienna.
Aktive Positionen von Eva Prieschl-Grassauer
Unternehmen | Position | Beginn |
---|---|---|
MARINOMED BIOTECH AG | Founder | 01.01.2006 |
Ehemalige bekannte Positionen von Eva Prieschl-Grassauer
Unternehmen | Position | Ende |
---|---|---|
Onepharma | Corporate Officer/Principal | 01.07.2006 |
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | 01.01.2006 |
Wyeth Pharmaceuticals BV | Corporate Officer/Principal | 01.10.2002 |
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
Ausbildung von Eva Prieschl-Grassauer
University of Vienna | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MARINOMED BIOTECH AG | Health Technology |
Private Unternehmen | 4 |
---|---|
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Health Technology |
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Health Technology |
Wyeth Pharmaceuticals BV | |
Onepharma |